A dual-target CAR T cell therapy approach shows promise for slowing tumor growth in a notoriously aggressive and fast-growing ...

New research suggests that blood tests known as “liquid biopsies” can improve the treatment of some people with metastatic ...

Treating breast cancer patients with AstraZeneca's experimental pill camizestrant at the first sign of resistance to standard ...

AstraZeneca's experimental drug, camizestrant, significantly reduces the risk of breast cancer progression or death in ...

In patients with an advanced type of skin cancer called cutaneous squamous cell carcinoma (cSCC), those who received the ...

Pharmaceutical companies are making billions on treatments that can sometimes overpromise and underdeliver for terminal cases ...

The American Institute of Cancer Research recommends a diet filled with a variety of fruits, vegetables, grains and ...

As prostate cancer progresses, it becomes increasingly aggressive and can metastasize. In this form, the tumor is difficult to treat, which is reflected in high mortality rates: Worldwide, the ...

A dual-target CAR T cell therapy approach shows promise for slowing tumor growth in a notoriously aggressive and fast-growing ...

A dual-target CAR T cell therapy approach shows promise for slowing tumor growth in a notoriously aggressive and fast-growing brain ...

In this form, the tumor is difficult to treat ... which leads to accelerated cancer growth. These results could explain why Prostate cancer is less responsive to immune therapy and could help ...